- The Trump administration is moving to let pharmacies compound popular peptides, a decision that could put the trendy wellness compounds within easier reach for millions of Americans.
- Peptides have surged in popularity for everything from muscle recovery to anti-aging, often promoted heavily on social media.
- Supporters argue the change expands access and gives patients more options, while critics warn about safety and the lack of rigorous testing.
AI-generated briefing — triage, not the story; every claim links out to the coverage below.
Latest video
Powered by TPD Video
In this story
OrgTrump AdministrationOrgNPRTopicPeptide CompoundingTopicDrug Regulation
Reader pollAdvertisement
Powered by Sided
The Conversation
Additional Coverage
WebsiteRFK Jr. eases access to unproven peptides despite opposition from FDA scientists↗
